Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: J Neurooncol. 2016 Oct 21;131(2):301–311. doi: 10.1007/s11060-016-2294-7

Fig. 2.

Fig. 2

Overall survival according to treatment group, starting 60 days following diagnosis. *Numbers less than 11, or changes in number of less than 11 cases between timepoints, are not reported consistent with SEER-medicare confidentiality policies. TMZ temozolomide, RT radiotherapy, SEER surveillance, epidemiology and end results